SCHEMBL3852029

SCHEMBL3852029

COc1ccc(-c2ccn(C(c3ccccc3)(c3ccccc3)c3ccccc3)n2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.43
JAK2 O60674 1/20 0.43
ATR Q13535 1/20 0.39
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP11B1 P15538 1/20 0.39
OXTR P30559 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
CYP19A1 P11511 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP2A6 P11509 1/20 0.38
GRM5 P41594 1/20 0.37
EPHB4 P54760 1/20 0.37
MAT2A P31153 1/20 0.37
FYN P06241 1/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845928 0.95 KDR (0.46) KDRJAK2MKNK1MKNK2L3MBTL1
SCHEMBL3846623 0.83 KMT2A (0.34) KDRJAK2CYP11B1CYP19A1KMT2A
SCHEMBL5800759 0.76 KMT2A (0.52) L3MBTL1CYP11B1MEN1KMT2ANPC1
SCHEMBL4868116 0.76 ENPP2 (0.50) KDRATRMKNK1MKNK2CYP11B1
SCHEMBL3846335 0.76 KDR (0.38) KDRJAK2ATRMKNK1MKNK2
SCHEMBL3846751 0.76 KMT2A (0.44) L3MBTL1MEN1KMT2ANPC1LMNA
SCHEMBL13874174 0.75 KEAP1 (0.49) JAK2MKNK1MKNK2CYP11B1HSD17B1
SCHEMBL28044043 0.75 MAOB (0.43) FYNNPC1
SCHEMBL3850285 0.74 ALDH1A1 (0.49) L3MBTL1MEN1KMT2ANPC1PKM
SCHEMBL3848389 0.74 KDR (0.37) KDRJAK2ATRMKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed